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Janna’s Story: What Cancer Gave Me
By Bridgette Frommell, Foundation Development Officer, Aurora St. Luke’s Medical Center

At age 32, Janna Ripp had never taken any serious
medications or even stayed overnight in a hospital, so
you can imagine how her world came to a stop when she
was told she had cancer.
“The air felt like it was sucked out of the room,” Janna
says. “I had questions and my brain was spinning with
thoughts. I was in total disbelief.”

Janna shared her story at this year’s Lombardi Walk
for Cancer in Oshkosh, and was thankful for the care
she received.
“All of the nurses, doctors, CNAs, housekeepers,
receptionists and social workers I met through Aurora….
Everything you have done has played a part in getting me
to this point,” said Janna.
And instead of focusing on what cancer took away from
her life, Janna remains focused on what it has given her
– friendships that have been tested and strengthened,
new bonds with other cancer patients that go deeper than
anything she imagined, and most of all, knowing that
she has the strength and willpower to live, no matter
the odds.
You can still support local cancer care by making a gift
to the Vince Lombardi Cancer Walk in Oshkosh,
Walworth County or Milwaukee Walk/Run events.
Visit aurora.org/cancerwalk for more information.

Janna (far right) and her sisters prior to her cancer diagnosis.

Janna was diagnosed with acute lymphocytic leukemia
(ALL), a blood cancer most commonly associated with
young children and older adults.
Janna, of course, was neither. “One day I’m going to work
like a normal person and the next I am told that without
treatment, I had 3-6 months to live.“
She was told right away that part of her treatment would
include staying at least 30 days inpatient at Aurora
St. Luke’s Medical Center in Milwaukee. Janna heard
the words, but couldn’t accept it. So, in the six weeks
following her diagnosis, Janna went in regularly for lab
work and received platelet and blood transfusions, but
waited to start chemotherapy. Instead, she tried an
extreme diet, going completely raw and organic. She
shared she had hoped to clean out the toxins in her body
and rid herself of the cancer. But unfortunately, that
wasn’t enough, and Janna decided to move forward
with chemotherapy.
Janna stayed at Aurora St. Luke’s for 33 days, and had
nine more rounds of chemotherapy after that. But thanks
to the level of care she received, Janna is now able to call
herself a cancer survivor. She just passed her one-year
mark since her initial diagnosis.
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WVBO’s Skip Willis with Janna at the Lombardi Walk for Cancer.

Lung Cancer Screening:
Frequently Asked Questions
By Steven Leh MD, Interventional Pulmonologist, Chair of the System Lung Cancer Quality Committee,
Aurora Cancer Care; Marian Hansen and Sharon Gray, Care Management, Aurora Health Care

Lung cancer is the number one cancer killer in the
United States. With over 155,000 deaths per year,
lung cancer kills more people than breast, colon, and
prostate cancer combined. If you’re a smoker or a
former smoker you may worry about your risk of getting
lung cancer or dying from it. Lung cancer can be highly
curable when found early but in the past the early stage
of lung cancer has been hard to detect.
A recent major study of heavy smokers, called the
National Lung Screening Trail, compared screening for
lung cancer using lung CT scans and chest x-rays. The
study showed that using lung CT scan for screening
lowered the risk of dying from lung cancer by 20%. This
is the first study to show that lung cancer screening may
save lives.
If you have additional questions after reading this
material, please call 855-229-0924.
What is the goal of lung cancer screening?
The goal of lung cancer screening is to save lives. If no
screening is done, lung cancer is usually not found until
a person develops symptoms. By the time you have
symptoms, the cancer is more advanced and much
harder to treat.
Who should get an LDCT lung screening exam?
Smoking is still the biggest cause of lung cancer. People
who have never smoked can get lung cancer but the
risk is low compared to those that smoke. People who
have smoked are at ten to 20 times the risk of people
who have never smoked. Lung cancer screening is
recommended for people who are at high risk for
lung cancer.

I am at high risk but have been diagnosed with cancer
in the past. Is LDCT lung screening appropriate for me?
It depends. In some cases, LDCT lung screening will
not be appropriate, such as when your doctor is already
following your cancer with CT scan studies. Your doctor
will help determine if LDCT lung screening is right
for you.
Do I need to have an LDCT lung screening exam
every year?
Screening for lung cancer is not a one-time test, but
a process that involves a periodic evaluation of your
lungs over time to look for newly emerging cancer. The
capability of CT scanners to detect tiny lung nodules
and to compare the nodules for changes in size over
time is critical to the screening process. If you are
considered high-risk an LDCT lung screening exam is
recommended every year until you are 74, for 15 years
after you have quit smoking, or for major changes in
your health status.
How is the exam performed?
LDCT lung screening is one of the easiest screening
exams you can have. The exam takes less than 10
seconds. No medications are given, and no needles are
used. You can eat before and after the exam. You do
not even need to get changed as long as the clothing on
your chest does not contain metal. You must be able to
hold your breath for at least 6 seconds while the chest
scan is being taken. If you are not feeling well or if you
have lung symptoms on the day of the CT scan you
should not have the test.
Are there any risks to LDCT lung screening?

Screening exams should be done for people who are
at high risk but have no symptoms related to lung
cancer. This group includes people aged 55 to 74 who
have smoked at least one pack of cigarettes a day for 30
years. This includes people who still smoke or have quit
within the last 15 years.

LDCT lung screening is safe however there are some
risks associated with the screening study. We want to
make sure that we have done a good job explaining
these to you, so please let us know if you have any
questions. Your health care provider who ordered the
screening may want to talk with you more about this:

Why does it matter if I have symptoms?

• Radiation exposure: LDCT lung screening uses 		
radiation to create images of your lung. Radiation
can increase a person’s risk of cancer. By using
special techniques, the amount of radiation in LDCT
lung screening is small—about the same amount a
person would receive from a screening
mammogram. Further, your doctor has determined
that the benefits of the screening outweigh the risks
of being exposed to the small amount of radiation
from this exam.

Lung cancer screening is done in case there is
something developing that a person is not aware of.
Symptoms of lung problems can affect the results of
the screening test. If you already have symptoms you
should be evaluated and treated by your healthcare
provider. These symptoms include fever, chest pain,
a new or changing cough, shortness of breath that
you have never felt before, coughing up blood, or
unexplained weight loss.
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• False negatives: No test, including LDCT lung screening,
is perfect. It is possible that you may have a medical
condition, including lung cancer, which is not found
during your exam. This is called a false negative.
What can I expect from the results?
LDCT scanning is done to find small nodules in the lungs
that may be cancer but are not yet causing symptoms. Lung
nodules are small collections of abnormal tissue. Lung
CT screening very often finds something in the lungs that
could be cancer but in fact is not. Finding nodules that are
not cancer is called a “false positive”. False positive tests
may cause anxiety but only about 3% of the nodules found
will be cancer. In order to make sure these findings are not
cancer you may need to have more testing. Occasionally a
person might need a procedure, such as a biopsy. If a small
nodule is found to be cancer, the cancer can be cured more
than 90% of the time. That is why we are screening you.
When will I get the results?
You will receive the results of your exam within 72 hours.
If you do not hear from us within that time frame please be
sure to call us at 855-229-0924.
Will my doctor also receive the results?
Yes. Your healthcare provider who ordered your exam
AND your primary care physician will receive a copy of
your results.
How much does the screening cost?
Currently, LDCT lung screening is offered by select Aurora
Health Care sites at a cost of $99. Any additional testing you
may need, based on the results from the screening, will be
billed to your insurance. Most insurance companies will
cover the cost of these additional tests subject to your plan’s
co-pay and deductible levels.
Do I have any obligations to Aurora Health Care or any of
Aurora hospitals if I have the screening?
The screening does not obligate you to return to Aurora
Health Care or any of its hospitals for any further screenings,
for further evaluation of any findings, or for any other
services that Aurora provides.
Where can I find help to quit smoking?
The best way to prevent lung cancer is to stop smoking. For
help on quitting smoking, please call the Wisconsin Quit
Line at 800-QUIT-NOW or 800-784-8669 or visit wiquit.org.
If you have already quit smoking, congratulations and keep
it up! Remember to also follow up with your primary care
physician for an annual physical.
I think I qualify for LDCT lung screening.
What should I do next?
Call 855-229-0924 to see if you qualify and to schedule
your exam. Please note that we will need an order for
LDCT lung screening from your healthcare provider
before your exam.

Clinical Teaching
at Aurora Cancer
Care Pharmacy
By Peter Stuessy, PharmD,BCPS- Clinical Pharmacist, Senior,
Aurora Cancer Care

The pharmacy department at Aurora Cancer Care is
involved with pharmacy education on many levels.
Pharmacy students and residents are part of the team
and are involved in a number of ways at Aurora clinics.
Students from Concordia University School of
Pharmacy in Mequon, Creighton University in Omaha,
Nebraska, and the University of Wisconsin School of
Pharmacy in Madison all learn at the clinics. Some
students are in their first three years of pharmacy
school and do week long rotations, but most are in their
final (fourth) year of school. They join the pharmacy
department for 6-8 week blocks where they learn
about being an oncology clinic pharmacist. Tasks
include checking chemotherapy preparation, talking to
patients about take home prescriptions, answering drug
information questions from caregivers and patients,
and working on projects for the pharmacy department.
Post graduate year one (PGY-1) pharmacy residents
can also participate in rotations at Aurora Cancer
Care. Residents are licensed pharmacists who have
committed to a one-year training program. Residents
at the South clinic and at the Green Bay clinic have
six-week rotations where they check chemotherapy
preparation, consult patients on medications, and
call back patients who are starting chemotherapy to
see how they are doing. They also help precept our
pharmacy students, research and present topics for
discussion, and answer drug questions. The goal is for
them to learn everything a pharmacist does at the clinic
so that they can then work as the pharmacist by the end
of the six weeks.
Post graduate year two (PGY-2) specialty pharmacy
oncology residents are pharmacists who have
completed their PGY-1 residency and are doing a
second resident year specializing in cancer care.
They work at or with the Aurora Cancer Care clinics
many times through their year, but do rotations at
the South and West Allis clinics. These residents
do everything the staff pharmacist does, providing
consultation and teaching to patients on chemotherapy
and prescriptions, help precept students and PGY-1
residents, answer drug information questions, and lead
discussions on cancer pharmacy topics.
Student and resident teaching is an important part
of the pharmacy department at Aurora Cancer Care.
The pharmacists act as preceptors who grade their
work and teach them, but time with our patients and
other caregivers teach them a lot too. Thanks to all the
caregivers and patients of Aurora Cancer Care for their
support of these learners!
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EMMI Solutions and Aurora Cancer Care: Using
technology to meet the patient where they are
By Erik Hollander, MBA, Community Outreach Coordinator, Aurora Cancer Care

You have cancer. Three words we hope that nobody ever
hears, but the reality, according to the American Cancer
Society’s Wisconsin Facts and Figures 2014, is that every
day in Wisconsin 87 people will hear those three words,
“You have cancer.”
During a time that is filled with so many questions,
emotions and thoughts, Aurora Cancer Care has
partnered with Expectation Management and Medical
Information (EMMI®) Solutions to provide cancer
patients with a new way of receiving information
related to their cancer treatment.
Aurora Cancer Care has recorded over 50 specific
intravenous (IV)-related cancer drug videos that will
provide basic information about the drugs and also
potential side effects, outcomes and follow-up. All of
this will be made accessible at the tip of your finger
through various electronic devices (i.e. iPhone, iPad,
tablet, cell phone, desktop computer, laptop computer,
etc.). Patients needing chemotherapy will first watch
a general teaching video about chemotherapy using
EMMI. The EMMI format also allows us to send the
link to your MyAurora or home email. Access to EMMI
will be launched across all of our 22 sites beginning
late 2014 and will be completed mid-2015. The drugspecific videos will be available to patients by the end of
this year.

These videos will run between 20-45 minutes and
provide the opportunity to write down questions while
working to alleviate the stress and distress by answering
many frequently asked questions. When done viewing
any of these videos, a nurse from your care team will
contact you to ensure your comfort and understanding
of any of the information you have reviewed prior
to treatment.
We are truly excited for the opportunity to bring this
type of education to patients by providing the way for us
to meet them in a place of comfort to view this sensitive
information. It is our hope and commitment to ensure a
stronger standard of care, increase efficiency in clinics,
increase effectiveness for all learners, and provide a
way to hear, listen and understand the information in a
timely manner to help your care team provide you with
the best possible care.
Aurora Cancer Care is already in the midst of recording
similar videos specifically related to the ever-increasing
use of oral chemotherapy medications. We plan to
annually add video content for new drugs and modify
any recommendations related to those videos we have
already recorded. We are very excited to bring this
aspect of patient care to your fingertips so we may work
as a team to provide you with the best possible care to
achieve the best possible outcomes!

Abstracts Accepted by the ASCO
By Anne Weers, RN, MS- System Program Quality Manager-Cancer Services System Clinical Program Office

The Aurora Cancer Program is proud to announce the
acceptance of five abstracts by the American Society
of Clinical Oncology (ASCO). ASCO is a national
professional organization representing physicians of
all oncology subspecialties who care for people with
cancer. The abstracts include brief summaries of active
research or an in-depth analysis of relevant projects
within the Aurora Cancer Care Program. The abstracts
will be presented at the 2014 ASCO Quality Care
Symposium to be held in Boston, MA in October. The
ASCO Planning Committee reviewed over 330 abstract
submissions for the Symposium. We are pleased to
recognize the following Providers who continue to
cultivate Aurora’s commitment to providing all patients
with the highest quality of cancer care through their
research efforts:
• Barry-Weers A, Huibregtse C, Ihde S, Bjegovich
Weidman M, Weese J. Getting quality data back to
frontline providers.

• Santhosh-Kumar C, Theodoroff M,
Gray D, Huibregtse C. Barriers to clinical trial accrual
in a community cancer clinic.
• Rathod H, Yoder SA. Interventions to optimize the
use of colony-stimulating factors.
• Poggi L, Godden J, Yoder S. A standardized approach
for managing chemotherapy-induced rash.
• Feldt A, Godden J. Implementation of pharmacy
services in 22 oncology clinics.
In addition, all of the abstracts will be published in the
Journal of Clinical Oncology. The Journal of Clinical
Oncology is a peer-reviewed medical journal published
3 times a month by the American Society of Clinical
Oncology. It covers research on all aspects of clinical
oncology. The highly respected Journal now accounts
for nearly 1 in 10 of all oncology journal citations and
includes 10 international editions.
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